News

Thermo Fisher Scientific's $13.6 Billion Acquisition of Life Technologies Boosts Flagging M&A Numbers May 01, 2013 | Press Release

Burrill Securities Launches Institutional Breakthrough Series April 29, 2013 | Press Release

Big Biotech Outpaces Big Pharma, Burrill & Company says April 16, 2013 | Press Release

  See all News
 
Sign up to receive email notifications about our upcoming events and news.


Burrill Venture Capital



Burrill Venture Capital actively seeks investment opportunities outside of the United States. We invest in life science companies whose technologies and products are principally focused on improvements in human healthcare.


Learn more about Burrill Venture Capital

International Merchant Banking

Burrill Merchant Banking advises life science companies on cross-border transactions, including M&A, strategic partnerships, spin-outs, private placements,and strategic development. 


Learn more about Burrill Merchant Banking

International Conferences



Burrill conferences examine the world of the life sciences from a global perspective.


See all upcoming Burrill Conferences